Does TRT Cause Acne? What the Evidence Shows

Gym culture still runs two incompatible headlines about TRT and skin: either starting testosterone means you will break out like a teenager, or acne only happens on “blasts,” so physiologic replacement is skin-safe forever.

Neither slogan matches the evidence stack. Across placebo-controlled testosterone trials that actually reported acne, cumulative incidence was higher on testosterone than placebo — roughly 7.8% vs 5.1% in a 2026 systematic review of larger RCTs, with a pooled risk ratio near 1.4 (Deitelzweig et al., JID abstract). A separate 2026 scoping review of dermatologic adverse effects in adult men on TRT found acne to be the most frequent skin event, typically in a low single-digit to ~9% band depending on study and formulation, usually mild and early (Sexual Medicine Reviews scoping review). Higher risk than placebo is real. Guaranteed cystic ruin for every man on replacement is not.

This is a Research / Evidence Update for athletes and performance-minded men on or considering testosterone therapy. It is education for a licensed-provider conversation — not a dermatology diagnosis, not an isotretinoin or antibiotic protocol, and not advice to start, stop, or change any medication.

If your question is hairline risk, use Does TRT cause hair loss?. If the claim is breast-tissue growth, use Does TRT cause gynecomastia?. If you need the post-start lab checklist, use What should you recheck after starting TRT?. This page owns the does TRT cause acne evidence question.

What Changed — and Why Athletes Care Now

Three things moved the conversation past forum anecdotes:

1. Dermatology outcomes were historically under-captured in testosterone RCTs — many large trials never listed acne as a reported adverse event at all.
2. 2025–2026 evidence syntheses finally pooled what was reported: a JID systematic review of placebo-controlled testosterone RCTs (≥100 adults) and a Sexual Medicine Reviews scoping review focused on dermatologic adverse effects in adult men on TRT.
3. Route and population nuance is clearer — injectable regimens often look oilier than oral formulations in adult-men TRT cohorts; transmasculine hormone-therapy literature reports substantially higher acne prevalence than typical hypogonadal replacement cohorts, so those numbers should not be copy-pasted onto every TRT patient.

Athletes care because skin is adherence. A man who starts clinician-directed testosterone and then ghost-stops after two months of back and shoulder breakouts is a compliance problem dressed as a vanity problem. Counseling needs a number band and a honesty clause — not “you will definitely get acne” and not “TRT never touches skin.”

What was thin in our library: a dedicated page whose primary purpose is acne risk on TRT — separate from DHT/hair myths and separate from estradiol/gyno myths.

Previous Understanding

Three athlete slogans dominated for years:

• Panic lore: Exogenous testosterone always floods sebum; every man on TRT will get cystic acne.
• Immunity lore: Only blasts and “ tren face” cause breakouts; physiologic replacement is dermatologically inert.
• Clinic shorthand: Acne is a known androgen side effect, usually mild, under-reported in trials, and worth counseling — but the quantitative band was fuzzy outside specialty clinics.

All three contain a grain of truth. Androgens stimulate sebaceous glands. Supraphysiologic stacks are a different exposure class than dose-adjusted replacement. Acne appears on product labels and in clinical experience. None of those facts settles how often monitored TRT patients in RCTs actually report acne versus placebo.

New Evidence

RCT synthesis: acne more common on testosterone than placebo

A 2026 systematic review screened thousands of records and included 93 placebo-controlled RCTs of testosterone therapy with 100+ adults. Only about 30% of those trials reported any dermatologic outcome; only ~12% reported at least one acne case — a reminder that skin adverse events are selectively documented (Deitelzweig et al., JID).

Among the trials that did report acne:

Pooled Mantel–Haenszel risk ratio 1.39 (95% CI 1.10–1.76); no heterogeneity reported across those RCTs (I² = 0% in the abstract). Authors note selective adverse-event reporting bias and exclusion of smaller trials as limits — and that almost no included RCTs listed a dermatologist co-author.

Athlete reading: When trials bother to count acne, testosterone raises risk versus placebo. Absolute rates in that reporting subset stay in the high-single-digit band for testosterone — not a majority outcome. “More than placebo” is not “almost everyone.”

Scoping review in adult men on TRT: acne leads the skin list

A 2026 scoping review of dermatologic adverse effects of TRT in adult men (ten eligible studies spanning prospective trials and chart reviews, 2006–2025) found dermatologic events consistently reported, with acne the most frequent skin reaction — roughly 0.6%–9.1% across included studies, lowest in some oral formulations, with injectable preparations generally associated with higher acne and systemic skin-reaction rates than topical or oral routes in the narrative synthesis (Sexual Medicine Reviews). Pruritus, rashes, and abnormal hair growth appeared in lower single-digit to ~10% bands depending on the event. Most described events were early (often within 3–12 months) and mild; discontinuation for acne was uncommon in the summarized literature.

Athlete reading: Oily skin and breakouts belong in the informed-consent conversation for TRT. They are usually framed as manageable dermatologic adverse effects, not as proof that replacement is unsafe or that you must abandon therapy without a clinician.

Why gym screenshots over-read (and under-read) the risk

Transmasculine masculinizing-hormone literature often reports substantially higher acne prevalence (methodology-dependent bands far above typical hypogonadal TRT AE rates) and peaks in the months after initiation. That literature is useful for mechanism and counseling intensity in that population. It is not a drop-in incidence estimate for every middle-aged hypogonadal man on physiologic replacement.

What the Evidence Does Not Establish

The 2026 syntheses do not prove:

• That every man starting TRT will develop acne
• That acne severity on TRT matches adolescent cystic disease for most patients
• That a single oily week means your trough is “too high” without timing, formulation, and clinical context
• That labs alone (total T, free T, DHT, estradiol) diagnose or grade acne
• That stopping TRT without clinician guidance is required at the first whitehead
• That Anabolic Insights — or any article — can prescribe dermatology treatment, isotretinoin, antibiotics, or dose changes

It also does not authorize DIY “estrogen crash to dry out skin,” unsupervised anastrozole for acne, or blaming every shoulder breakout on testosterone while ignoring occlusive athletic gear, dairy/glycemic context, sleep debt, or skincare hygiene.

Proprietary Anabolic Insights aggregate data on member-reported acne after starting testosterone is not available for this article — do not invent platform rates.

Athlete Relevance

Hard-training men usually meet this question in three ways:

1. Pre-start anxiety — family acne history or a bad teenage decade becomes a veto on clinician-directed TRT
2. Early-protocol panic — months 1–6 bring oilier T-zone / back / shoulders while training gear traps sweat and friction
3. Forum category errors — blast-and-cruise photo diaries get labeled “TRT acne,” then applied to physiologic replacement

Useful companions when a clinician reviews skin next to testosterone therapy:

For a hormone-forward baseline before or during a provider conversation, see Vital Metrics Men's Edition. Deeper androgen and performance markers live on Performance Metrics Men's Edition. Mid-protocol organ and metabolic checks often use the Monitoring Panel. Soft product context only — ordering labs does not grade acne or authorize dermatology drugs.

Practical Implications

1. Counsel for increased acne risk — not inevitability. RCT synthesis and adult-men TRT reviews support a real rise versus placebo / a leading dermatologic AE, usually in low-to-mid single digits when counted.
2. Expect the window. Reviews describe many dermatologic events in the early months (often 3–12). Early oil does not automatically mean lifelong cystic disease.
3. Keep formulation in the conversation. Injectable routes are repeatedly associated with higher acne signal than some oral or topical options in adult-men summaries — discuss route with your prescriber rather than forum-swapping products.
4. Do not use acne as a solo dosing algorithm. Skin changes belong next to symptoms, draw timing, and the post-start recheck checklist — not as a replacement for clinician judgment.
5. Separate skin from hair and breast myths. Hair-loss and gynecomastia pages own those claims. Acne is sebaceous and follicular — related androgen biology, different clinical endpoint.
6. Medication and dermatology decisions stay licensed. Testosterone is prescribed only when clinically appropriate. Acne treatment — topical, systemic, or otherwise — is a clinician call.

Questions Still Unanswered

• How often do modern injectable regimens in resistance-trained men under 40 produce moderate-to-severe acne versus the mixed-indication RCTs that reported any acne at all?
• Does proactive, guideline-driven acne care at TRT initiation change persistence and severity across routes?
• How should clinicians weight gel vs injectable acne signals when hematocrit, convenience, and symptom control pull in different directions?
• What fraction of “TRT acne” in gym culture is androgen-driven sebaceous change vs occlusion, friction, and recovery stress from training?

Until those answers are cleaner, the honest frame is elevated but usually minority risk, often early and mild, formulation-sensitive, and worth counseling — not “TRT means cystic acne,” and not “skin is irrelevant on testosterone.”

Bottom Line

For the question athletes actually type — does TRT cause acne? — the best recent evidence says risk rises versus placebo when trials report the outcome, and acne is the most common dermatologic adverse effect in adult-men TRT reviews, typically landing in a low-single-digit to ~9% band and often mild in the early months. That is enough to counsel and plan. It is not enough to treat breakouts as destiny or to ignore non-androgen skin amplifiers. Bring formulation, timing, training gear, and symptoms to a licensed clinician — and keep hair-loss and gynecomastia claims on their own pages.

FAQs

Does TRT always cause acne? No. Evidence supports higher risk than placebo and acne as a leading skin AE — not a near-universal outcome for every man on physiologic replacement.

How common is acne on testosterone therapy? In the 2026 RCT synthesis that reported acne, cumulative incidence was about 7.8% on testosterone vs 5.1% on placebo. Adult-men TRT dermatology reviews often cite roughly 0.6%–9.1% depending on study and formulation. Selective reporting means real-world rates could differ.

Do injectables cause more acne than gels or oral options? Adult-men summaries generally associate injectable preparations with higher acne and systemic skin-reaction rates than some topical or oral routes. That is a counseling signal for your prescriber — not a self-directed product swap.

Will checking DHT or estradiol tell me if I will get acne? No. Androgen and estrogen labs contextualize therapy; they do not grade sebaceous activity or replace a skin exam. See the DHT panel guide when hair is the question, and sensitive-estradiol resources when breast symptoms are the question.

Should I stop TRT if I break out? Do not stop or change prescribed testosterone on a forum screenshot. Discuss severity, formulation, skincare, and options with the prescribing clinician and, when needed, a dermatology clinician.